01 Rising demand for ambulatory and portable infusion pumpsThe global intravenous infusion pump market is witnessing growing demand for ambulatory and portable devices, driven by the shift toward home healthcare and outpatient care models. Patients increasingly prefer compact and easy-to-use systems that enable continuous treatment outside hospitals, supporting independence, comfort, and adherence to prescribed therapies.This trend is further reinforced by rising cases of chronic illnesses, where long-term drug administration is essential. Portable infusion pumps are proving vital in oncology, pain management, and diabetes care, offering flexibility without compromising safety. Their adoption highlights the healthcare industry’s focus on patient-centered solutions and technology-driven convenience.
01 Rising prevalence of chronic illnessesThe global intravenous infusion pump market is being driven by the rising prevalence of chronic illnesses, which are placing an increasing demand on continuous and precise medication delivery. Patients with conditions such as diabetes and cardiovascular diseases require long-term infusion therapies, both in hospitals and home care settings.This growing burden of chronic diseases is encouraging healthcare providers to adopt advanced infusion pumps that ensure safety, accuracy, and convenience for patients.
01 Frequent reports of device recalls and malfunctionsThe global intravenous infusion pump market faces challenges due to frequent reports of device recalls and malfunctions. Such issues raise concerns about patient safety and reliability, leading to cautious adoption among healthcare providers. Malfunctions can result from software glitches, hardware failures, or improper usage, prompting regulatory scrutiny and increased compliance requirements. These incidents not only affect manufacturer credibility but also slow market growth, as hospitals and clinics prioritize proven, safe devices over newer, untested models. Addressing these risks is critical for sustaining trust and adoption.
01 Advancing smart pumps through IoT, AI & EHR integrationThe global intravenous infusion pump market presents significant opportunities with the advancement of smart pumps through IoT, AI, and EHR integration. Healthcare providers are increasingly seeking automated and connected systems that improve workflow efficiency, reduce human error, and enhance patient safety.These innovations highlight the market’s focus on technology-driven, patient-centered solutions that optimize clinical outcomes.
June 2026 B. Braun expanded its infusion therapy portfolio with advancements in Spaceplus infusion pump systems and digital connectivity solutions. The company focused on improving medication safety, workflow efficiency, and smart hospital integration.
March 2026 Baxter expanded its infusion pump technologies with enhancements to the Novum IQ infusion platform. The solutions support connected medication delivery, interoperability, and improved clinical decision-making in hospitals.
January 2026 Fresenius Kabi expanded its infusion pump portfolio with new digital features and safety-focused technologies. The company continued strengthening its Volumat and Agilia infusion systems for hospitals and healthcare facilities.
October 2025 ICU Medical expanded its Plum 360 infusion system capabilities with software enhancements supporting medication safety and interoperability. The company continued advancing smart infusion solutions for acute care environments.